These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8438464)
41. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts. Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M Transplant Proc; 1996 Jun; 28(3):1368-9. PubMed ID: 8658698 [No Abstract] [Full Text] [Related]
42. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
43. Examination of sex-associated differences and organ specificities in the survival of cardiac and skin allografts in rats treated with cyclosporine. Enosawa S; Hirasawa K Transplantation; 1989 Oct; 48(4):714-7. PubMed ID: 2799934 [No Abstract] [Full Text] [Related]
44. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides. Schorlemmer HU; Schwab W; Ruuth E; Kurrle R Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182 [No Abstract] [Full Text] [Related]
45. Cylexin: a P-selectin inhibitor prolongs heart allograft survival in hypersensitized rat recipients. Park IY; Lee DS; Song MH; Kim W; Won JM Transplant Proc; 1998 Nov; 30(7):2927-8. PubMed ID: 9838290 [No Abstract] [Full Text] [Related]
46. Rat heart allograft survival after treatment with verapamil, captopril, and enalapril. Mjörnstedt L; Lukes D; Arvidsson N; Herlitz H; Olausson M Transplant Proc; 1995 Dec; 27(6):3544. PubMed ID: 8540093 [No Abstract] [Full Text] [Related]
47. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration. Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539 [TBL] [Abstract][Full Text] [Related]
48. Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival. Lussow AR; Fanget L; Gao L; Buelow R; Pouletty P Transplant Proc; 1996 Apr; 28(2):571-2. PubMed ID: 8623277 [No Abstract] [Full Text] [Related]
49. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats. Lin Y; Segers C; Waer M Transplant Proc; 1996 Dec; 28(6):3036. PubMed ID: 8962178 [No Abstract] [Full Text] [Related]
55. [Study of the immunosuppressive effect of cyclosporine in experimental studies]. Ivanitskaia LP; Suskova LV; Sutiusheva LV; Viadro MM; Zebrev AI; Nikitin AV Antibiot Khimioter; 1992 Feb; 37(2):33-7. PubMed ID: 1387520 [TBL] [Abstract][Full Text] [Related]
56. Prolongation of rat cardiac allograft survival by Ca++ blockers. Foegh ML; Khirabadi BS; Ramwell PW Transplantation; 1985 Aug; 40(2):211-2. PubMed ID: 3895629 [No Abstract] [Full Text] [Related]
57. Mechanism of enhancement in allografts: alloantibody does not accumulate in the graft but forms complexes with lymphocytes. Namyslowski A; Olszewski WL Transplant Proc; 1995 Oct; 27(5):2666-7. PubMed ID: 7482870 [No Abstract] [Full Text] [Related]
58. Gene transfer of immunosuppressive peptides B2702 and RDP1257 prolongs allograft survival: evidence suggesting a role for heme oxygenase-I. Magee JC; DeBruyne LA; Buelow R; Bromberg JS Transplant Proc; 1999; 31(1-2):1194. PubMed ID: 10083532 [No Abstract] [Full Text] [Related]
59. TAK-603, new rheumatic drug, inhibits rat mixed lymphocyte reactions and prolonges rat skin allograft survival. Fujita T; Ezoe K; Matsumoto Y; Saito T; Homma K; Jimbow K; Sato N Transplant Proc; 2002 Jun; 34(4):1133-5. PubMed ID: 12072297 [No Abstract] [Full Text] [Related]
60. Cyclosporine dosage requirements for rabbit skin allograft enhancement due to perioperative blood transfusion and cyclosporine synergy. Masendycz PJ; Dumble LJ; Francis DM; Clunie GJ Transplant Proc; 1987 Apr; 19(2):2895-7. PubMed ID: 3551232 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]